The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Erysipelas Vaccine Market Research Report 2024
Synopsis
Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months.
The global Swine Erysipelas Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Erysipelas Vaccine include Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological and Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Erysipelas Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Erysipelas Vaccine.
Report Scope
The Swine Erysipelas Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Erysipelas Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Erysipelas Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Boehringer Ingelheim
Qilu Animal Health
CAHIC
Chengdu Tianbang Biology
Jiujiang Bomeilai Biological
Jilin Zhengye Biological
Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
Segment by Type
Live
Inactivated
Segment by Application
Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Erysipelas Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Erysipelas Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months.
The global Swine Erysipelas Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Erysipelas Vaccine include Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological and Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Erysipelas Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Erysipelas Vaccine.
Report Scope
The Swine Erysipelas Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Erysipelas Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Erysipelas Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Boehringer Ingelheim
Qilu Animal Health
CAHIC
Chengdu Tianbang Biology
Jiujiang Bomeilai Biological
Jilin Zhengye Biological
Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
Segment by Type
Live
Inactivated
Segment by Application
Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Erysipelas Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Erysipelas Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Swine Erysipelas Vaccine Market Overview
1.1 Product Overview and Scope of Swine Erysipelas Vaccine
1.2 Swine Erysipelas Vaccine Segment by Type
1.2.1 Global Swine Erysipelas Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Live
1.2.3 Inactivated
1.3 Swine Erysipelas Vaccine Segment by Application
1.3.1 Global Swine Erysipelas Vaccine Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Swine Erysipelas Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Erysipelas Vaccine Revenue 2019-2030
1.4.2 Global Swine Erysipelas Vaccine Sales 2019-2030
1.4.3 Global Swine Erysipelas Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Erysipelas Vaccine Market Competition by Manufacturers
2.1 Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Erysipelas Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Erysipelas Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Swine Erysipelas Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Erysipelas Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Erysipelas Vaccine, Product Type & Application
2.7 Swine Erysipelas Vaccine Market Competitive Situation and Trends
2.7.1 Swine Erysipelas Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Erysipelas Vaccine Players Market Share by Revenue
2.7.3 Global Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Erysipelas Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Erysipelas Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Erysipelas Vaccine Global Swine Erysipelas Vaccine Sales by Region: 2019-2030
3.2.1 Global Swine Erysipelas Vaccine Sales by Region: 2019-2024
3.2.2 Global Swine Erysipelas Vaccine Sales by Region: 2025-2030
3.3 Global Swine Erysipelas Vaccine Global Swine Erysipelas Vaccine Revenue by Region: 2019-2030
3.3.1 Global Swine Erysipelas Vaccine Revenue by Region: 2019-2024
3.3.2 Global Swine Erysipelas Vaccine Revenue by Region: 2025-2030
3.4 North America Swine Erysipelas Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Erysipelas Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Erysipelas Vaccine Sales by Country (2019-2030)
3.4.3 North America Swine Erysipelas Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Erysipelas Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Erysipelas Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Erysipelas Vaccine Sales by Country (2019-2030)
3.5.3 Europe Swine Erysipelas Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Erysipelas Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Erysipelas Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Erysipelas Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Erysipelas Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Erysipelas Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Erysipelas Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Erysipelas Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Swine Erysipelas Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Erysipelas Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Erysipelas Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Erysipelas Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Erysipelas Vaccine Sales by Type (2019-2030)
4.1.1 Global Swine Erysipelas Vaccine Sales by Type (2019-2024)
4.1.2 Global Swine Erysipelas Vaccine Sales by Type (2025-2030)
4.1.3 Global Swine Erysipelas Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Swine Erysipelas Vaccine Revenue by Type (2019-2030)
4.2.1 Global Swine Erysipelas Vaccine Revenue by Type (2019-2024)
4.2.2 Global Swine Erysipelas Vaccine Revenue by Type (2025-2030)
4.2.3 Global Swine Erysipelas Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Swine Erysipelas Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Erysipelas Vaccine Sales by Application (2019-2030)
5.1.1 Global Swine Erysipelas Vaccine Sales by Application (2019-2024)
5.1.2 Global Swine Erysipelas Vaccine Sales by Application (2025-2030)
5.1.3 Global Swine Erysipelas Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Swine Erysipelas Vaccine Revenue by Application (2019-2030)
5.2.1 Global Swine Erysipelas Vaccine Revenue by Application (2019-2024)
5.2.2 Global Swine Erysipelas Vaccine Revenue by Application (2025-2030)
5.2.3 Global Swine Erysipelas Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Swine Erysipelas Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Swine Erysipelas Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Swine Erysipelas Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Qilu Animal Health
6.4.1 Qilu Animal Health Corporation Information
6.4.2 Qilu Animal Health Description and Business Overview
6.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio
6.4.5 Qilu Animal Health Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAHIC Swine Erysipelas Vaccine Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 Chengdu Tianbang Biology
6.6.1 Chengdu Tianbang Biology Corporation Information
6.6.2 Chengdu Tianbang Biology Description and Business Overview
6.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio
6.6.5 Chengdu Tianbang Biology Recent Developments/Updates
6.7 Jiujiang Bomeilai Biological
6.6.1 Jiujiang Bomeilai Biological Corporation Information
6.6.2 Jiujiang Bomeilai Biological Description and Business Overview
6.6.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio
6.7.5 Jiujiang Bomeilai Biological Recent Developments/Updates
6.8 Jilin Zhengye Biological
6.8.1 Jilin Zhengye Biological Corporation Information
6.8.2 Jilin Zhengye Biological Description and Business Overview
6.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio
6.8.5 Jilin Zhengye Biological Recent Developments/Updates
6.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
6.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information
6.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
6.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments/Updates
6.10 Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
6.10.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
6.10.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Erysipelas Vaccine Industry Chain Analysis
7.2 Swine Erysipelas Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Erysipelas Vaccine Production Mode & Process
7.4 Swine Erysipelas Vaccine Sales and Marketing
7.4.1 Swine Erysipelas Vaccine Sales Channels
7.4.2 Swine Erysipelas Vaccine Distributors
7.5 Swine Erysipelas Vaccine Customers
8 Swine Erysipelas Vaccine Market Dynamics
8.1 Swine Erysipelas Vaccine Industry Trends
8.2 Swine Erysipelas Vaccine Market Drivers
8.3 Swine Erysipelas Vaccine Market Challenges
8.4 Swine Erysipelas Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Swine Erysipelas Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Swine Erysipelas Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Swine Erysipelas Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Swine Erysipelas Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Swine Erysipelas Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Swine Erysipelas Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Swine Erysipelas Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Swine Erysipelas Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Erysipelas Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Swine Erysipelas Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Erysipelas Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Erysipelas Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Swine Erysipelas Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Swine Erysipelas Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Swine Erysipelas Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Swine Erysipelas Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Swine Erysipelas Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Swine Erysipelas Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Swine Erysipelas Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Swine Erysipelas Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Swine Erysipelas Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Swine Erysipelas Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Swine Erysipelas Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Swine Erysipelas Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Swine Erysipelas Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Swine Erysipelas Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Swine Erysipelas Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Swine Erysipelas Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Swine Erysipelas Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Swine Erysipelas Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Swine Erysipelas Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Swine Erysipelas Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Swine Erysipelas Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Swine Erysipelas Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Swine Erysipelas Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Swine Erysipelas Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Swine Erysipelas Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Swine Erysipelas Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Swine Erysipelas Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Swine Erysipelas Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Swine Erysipelas Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Swine Erysipelas Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Swine Erysipelas Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Swine Erysipelas Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Swine Erysipelas Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Swine Erysipelas Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Swine Erysipelas Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Swine Erysipelas Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Swine Erysipelas Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Swine Erysipelas Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Swine Erysipelas Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Swine Erysipelas Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Swine Erysipelas Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Zoetis Swine Erysipelas Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Swine Erysipelas Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Swine Erysipelas Vaccine Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Qilu Animal Health Corporation Information
Table 86. Qilu Animal Health Description and Business Overview
Table 87. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Qilu Animal Health Swine Erysipelas Vaccine Product
Table 89. Qilu Animal Health Recent Developments/Updates
Table 90. CAHIC Corporation Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. CAHIC Swine Erysipelas Vaccine Product
Table 94. CAHIC Recent Developments/Updates
Table 95. Chengdu Tianbang Biology Corporation Information
Table 96. Chengdu Tianbang Biology Description and Business Overview
Table 97. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product
Table 99. Chengdu Tianbang Biology Recent Developments/Updates
Table 100. Jiujiang Bomeilai Biological Corporation Information
Table 101. Jiujiang Bomeilai Biological Description and Business Overview
Table 102. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product
Table 104. Jiujiang Bomeilai Biological Recent Developments/Updates
Table 105. Jilin Zhengye Biological Corporation Information
Table 106. Jilin Zhengye Biological Description and Business Overview
Table 107. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Jilin Zhengye Biological Swine Erysipelas Vaccine Product
Table 109. Jilin Zhengye Biological Recent Developments/Updates
Table 110. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information
Table 111. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Description and Business Overview
Table 112. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product
Table 114. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments/Updates
Table 115. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Corporation Information
Table 116. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product
Table 119. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Swine Erysipelas Vaccine Distributors List
Table 123. Swine Erysipelas Vaccine Customers List
Table 124. Swine Erysipelas Vaccine Market Trends
Table 125. Swine Erysipelas Vaccine Market Drivers
Table 126. Swine Erysipelas Vaccine Market Challenges
Table 127. Swine Erysipelas Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Erysipelas Vaccine
Figure 2. Global Swine Erysipelas Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Swine Erysipelas Vaccine Market Share by Type in 2023 & 2030
Figure 4. Live Product Picture
Figure 5. Inactivated Product Picture
Figure 6. Global Swine Erysipelas Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Swine Erysipelas Vaccine Market Share by Application in 2023 & 2030
Figure 8. Pharmacy
Figure 9. Online Sale
Figure 10. Others
Figure 11. Global Swine Erysipelas Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Swine Erysipelas Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Swine Erysipelas Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Swine Erysipelas Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. Swine Erysipelas Vaccine Report Years Considered
Figure 16. Swine Erysipelas Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Swine Erysipelas Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Swine Erysipelas Vaccine Players: Market Share by Revenue in 2023
Figure 19. Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Swine Erysipelas Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Swine Erysipelas Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Swine Erysipelas Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Swine Erysipelas Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Swine Erysipelas Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Swine Erysipelas Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Swine Erysipelas Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Swine Erysipelas Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Swine Erysipelas Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Swine Erysipelas Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Swine Erysipelas Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Swine Erysipelas Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Swine Erysipelas Vaccine by Type (2019-2030)
Figure 55. Global Swine Erysipelas Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Swine Erysipelas Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Swine Erysipelas Vaccine by Application (2019-2030)
Figure 58. Global Swine Erysipelas Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Swine Erysipelas Vaccine Value Chain
Figure 60. Swine Erysipelas Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
